Cyclooctylamine - CAS 5452-37-9
Catalog: |
BB028706 |
Product Name: |
Cyclooctylamine |
CAS: |
5452-37-9 |
Synonyms: |
cyclooctanamine |
IUPAC Name: | cyclooctanamine |
Description: | Cyclooctylamine (CAS# 5452-37-9) is a useful research chemical compound. |
Molecular Weight: | 127.23 |
Molecular Formula: | C8H17N |
Canonical SMILES: | C1CCCC(CCC1)N |
InChI: | InChI=1S/C8H17N/c9-8-6-4-2-1-3-5-7-8/h8H,1-7,9H2 |
InChI Key: | HSOHBWMXECKEKV-UHFFFAOYSA-N |
Boiling Point: | 190 °C |
Melting Point: | -48 °C |
Purity: | 95 % |
Density: | 0.928 g/cm3 |
Solubility: | Soluble in water. 10.2 g/L at 20°C. |
Appearance: | Clear colorless to light yellow liquid |
MDL: | MFCD00001748 |
LogP: | 2.75830 |
GHS Hazard Statement: | H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] |
Precautionary Statement: | P260, P264, P280, P301+P330+P331, P303+P361+P353, P304+P340, P305+P351+P338, P310, P321, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-112281247-A | Method for preparing high-uniformity spandex through continuous polymerization | 20201030 |
CN-111362885-A | Benzothiazole ring substituted aminophenol oxygen radical zinc complex and preparation method and application thereof | 20200306 |
WO-2021172466-A1 | Catalyst for producing carboxylic acid ester, method for producing catalyst for producing carboxylic acid ester, and method for producing carboxylic acid ester | 20200228 |
US-2021261428-A1 | Methods and systems for treatment of lime to form vaterite | 20200225 |
US-2021261429-A1 | Methods and systems for treatment of limestone to form vaterite | 20200225 |
PMID | Publication Date | Title | Journal |
22606144 | 20120401 | Cyclo-octanaminium hydrogen succinate monohydrate | Acta crystallographica. Section E, Structure reports online |
20969830 | 20110201 | Functional reconstitution of influenza A M2(22-62) | Biochimica et biophysica acta |
20570509 | 20100715 | Interaction of aminoadamantane derivatives with the influenza A virus M2 channel-docking using a pore blocking model | Bioorganic & medicinal chemistry letters |
12110302 | 20020901 | Transport of the highly charged myo-inositol hexakisphosphate molecule across the red blood cell membrane: a phase transfer and biological study | Bioorganic & medicinal chemistry |
390559 | 19790101 | Ribavirin: an antiviral agent | Pharmacology & therapeutics |
Complexity: | 63 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 127.136099547 |
Formal Charge: | 0 |
Heavy Atom Count: | 9 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 1 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 127.136099547 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 26 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Nitrogen Compounds
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS